Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin and Umbilical Cord Blood Therapy in Stroke Patients
NCT04013646Phase 2Unknown
- Sponsor
- Cambridge Health Alliance
- Start
- May 2019
- Primary completion
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes, Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of umbilical cord blood and erythropoietin in stroke (3 arms), sponsored by Cambridge Health Alliance. Primary endpoint: Functional Independence Measure at 6 months. Status: unknown.
02
Drugs
umbilical cord blooderythropoietin
03
Conditions
stroke
Beyond the preview
Go deeper on NCT04013646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04013646.